Nucleic acid sequence and oncogenic properties of the HZ2 feline sarcoma virus v-abl insert
- PMID: 3029415
- PMCID: PMC254081
- DOI: 10.1128/JVI.61.4.1193-1202.1987
Nucleic acid sequence and oncogenic properties of the HZ2 feline sarcoma virus v-abl insert
Abstract
Hardy-Zuckerman 2 feline sarcoma virus (HZ2-FeSV), isolated from a multicentric feline fibrosarcoma is a replication-defective acute transforming feline retrovirus which originated by transduction of feline c-abl sequences with feline leukemia virus (FeLV) and is known to encode a 110-kilodalton gag-abl fusion protein with tyrosine-specific protein kinase activity (P. Besmer, W. D. Hardy, E. E. Zuckerman, P. J. Bergold, L. Lederman, and H. W. Snyder, Nature (London) 303:825-828, 1983). The nucleotide sequence of the abl segment in the HZ2-FeSV genome was determined and compared with the murine and human v-abl and c-abl sequences. The predicted transforming protein consists of 344 amino acids (aa) of FeLV gag origin, 439 aa of abl origin, and at least 200 aa of FeLV pol origin (p110gag-abl-pol). The 1,317-base-pair HZ2-FeSV v-abl segment (fv-abl) corresponds to 5' abl sequences which include the region known to specify the protein kinase domain. The 5' 189 base pairs of fv-abl correspond to 5' c-abl sequences not contained in Abelson murine leukemia virus (MuLV) v-abl. The mouse c-abl exon which contains these segments was identified, and its nucleotide sequence was determined. Comparison of the predicted amino acid sequence of fv-abl with those of Abelson MuLV v-abl and c-abl revealed five aa differences. The 5' junction between FeLV and abl was found to involve a preferred region in FeLV gag p30 (P. Besmer, J. E. Murphy, P. C. George, F. H. Qiu, P. J. Bergold, L. Lederman, H. W. Snyder, D. Brodeur, E. E. Zuckerman, and W. D. Hardy, Nature (London) 320:415-421, 1986). A six-base homology exists at the recombination site between the parental FeLV and the c-abl sequences. The 3' junction between fv-abl and FeLV pol predicts an in-frame fusion of fv-abl and FeLV pol. A transformed cell line containing a truncated gag-abl-pol protein, p85, that lacks most of the FeLV pol sequences was obtained by transfection of NIH 3T3 mouse cells. This result implies that the pol sequences of the p110gag-abl-pol protein are dispensable for fibroblast transformation. To assess whether the fv-abl segment specifies the unique biological properties of HZ2-FeSV, we constructed a Moloney MuLV-based version of HZ2-FeSV, Mo-MuLV(fv-abl), in which the fv-abl sequences were contained in a genetic context similar to that in HZ2-FeSV.(ABSTRACT TRUNCATED AT 400 WORDS)
Similar articles
-
Structure and origins of the HZ2-feline sarcoma virus.Virology. 1987 Jun;158(2):320-9. doi: 10.1016/0042-6822(87)90204-2. Virology. 1987. PMID: 2884777
-
A new acute transforming feline retrovirus with fms homology specifies a C-terminally truncated version of the c-fms protein that is different from SM-feline sarcoma virus v-fms protein.J Virol. 1986 Oct;60(1):194-203. doi: 10.1128/JVI.60.1.194-203.1986. J Virol. 1986. PMID: 3018286 Free PMC article.
-
McDonough feline sarcoma virus: characterization of the molecularly cloned provirus and its feline oncogene (v-fms).J Virol. 1982 Feb;41(2):489-500. doi: 10.1128/JVI.41.2.489-500.1982. J Virol. 1982. PMID: 6281462 Free PMC article.
-
A new acute transforming feline retrovirus and relationship of its oncogene v-kit with the protein kinase gene family.Nature. 1986 Apr 3-9;320(6061):415-21. doi: 10.1038/320415a0. Nature. 1986. PMID: 3007997
-
The Parodi-Irgens feline sarcoma virus and simian sarcoma virus have homologous oncogenes, but in different contexts of the viral genomes.J Virol. 1983 May;46(2):606-13. doi: 10.1128/JVI.46.2.606-613.1983. J Virol. 1983. PMID: 6302323 Free PMC article.
Cited by
-
Nucleotide sequence of testis-derived c-abl cDNAs: implications for testis-specific transcription and abl oncogene activation.Proc Natl Acad Sci U S A. 1987 Dec;84(23):8200-4. doi: 10.1073/pnas.84.23.8200. Proc Natl Acad Sci U S A. 1987. PMID: 3317402 Free PMC article.
-
Activation of murine c-abl protooncogene: effect of a point mutation on oncogenic activation.Proc Natl Acad Sci U S A. 1990 Sep;87(17):6502-6. doi: 10.1073/pnas.87.17.6502. Proc Natl Acad Sci U S A. 1990. PMID: 2168550 Free PMC article.
-
Primary structure of c-kit: relationship with the CSF-1/PDGF receptor kinase family--oncogenic activation of v-kit involves deletion of extracellular domain and C terminus.EMBO J. 1988 Apr;7(4):1003-11. doi: 10.1002/j.1460-2075.1988.tb02907.x. EMBO J. 1988. PMID: 2456920 Free PMC article.
-
Differences in oncogenic potency but not target cell specificity distinguish the two forms of the BCR/ABL oncogene.Mol Cell Biol. 1991 Sep;11(9):4710-6. doi: 10.1128/mcb.11.9.4710-4716.1991. Mol Cell Biol. 1991. PMID: 1875948 Free PMC article.
-
Temperature-sensitive mutants of Abelson murine leukemia virus deficient in protein tyrosine kinase activity.J Virol. 1990 Sep;64(9):4242-51. doi: 10.1128/JVI.64.9.4242-4251.1990. J Virol. 1990. PMID: 1696637 Free PMC article.
References
Publication types
MeSH terms
Substances
Associated data
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous